FDA Approved: SILIQ — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

FDA approved a supplemental application for SILIQ (brodalumab) submitted by Bausch Health US LLC to update the product labeling. The action concerns the approve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SILIQ (brodalumab)

Snippet

SUPPL AP for SILIQ (BRODALUMAB)